RecruitingPhase 3NCT03966014
Different Amoxicillin Treatment Regimens in Erythema Migrans Patients
Different Duration and Dosing of Amoxicillin in Patients With Erythema Migrans. A Randomized Clinical Trial.
Sponsor
University Medical Centre Ljubljana
Enrollment
200 participants
Start Date
Jun 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to compare the efficacy of different amoxicilline treatment regimens in patients with erythema migrans.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- erythema migrans
Exclusion Criteria5
- pregnancy
- extracutaneous manifestations of Lyme borreliosis
- immunocompromising state
- serious adverse event to beta lactam antibiotic
- receiving antibiotic with antiborrelial activity within 10 days
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGEM-amoxicillin 3 x 10 days
Patients will receive amoxicillin 500 milligram tid for 10 days
DRUGEM-amoxicillin 3 x 14 days
Patients will receive amoxicillin 500 milligram tid for 14 days
OTHERControls
No intervention.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03966014